For the quarter ending 2026-03-31, RNXT had $5,338K increase in cash & cash equivalents over the period. -$3,709K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Noncash lease expense | - | - | 23 | 42 |
| Net loss | -3,521 | -2,941 | -2,912 | -5,315 |
| Stock-based compensation expense | 317 | 285 | 349 | 633 |
| Non-cash lease expense | 23 | 88 | - | - |
| Change in fair value of common warrants classified as a liability | 97 | -506 | -175 | -234 |
| Depreciation expenses | 1 | 1 | -1 | 2 |
| Accounts receivable | 141 | -30 | -194 | 320 |
| Inventory | 190 | -83 | 272 | - |
| Prepaid expenses | 177 | -112 | -80 | 102 |
| Other current assets | -19 | 158 | -143 | -15 |
| Deferred offering costs | - | - | - | 0 |
| Accounts payable | 254 | -70 | 198 | 85 |
| Accrued expenses | -391 | 121 | 103 | -489 |
| Net cash used in operating activities | -3,709 | -3,020 | -2,270 | -5,683 |
| Purchase of property and equipment | 0 | 0 | 0 | 2 |
| Net cash used in investing activities | 0 | 0 | 0 | -2 |
| Gross proceeds from equity financing | - | - | 12,102 | - |
| Proceeds from common stock and pre-funded common stock warrants | 10,000 | 12,102 | - | - |
| Issuance cost of common stock upon private placement | 953 | 0 | 1,299 | - |
| Proceeds from exercise of common stock warrants | - | 0 | 0 | 25 |
| Proceeds from exercise of stock options | 0 | 0 | 0 | 17 |
| Proceeds from equity financing, net of issuance cost | - | - | - | 10,803 |
| Net cash provided by financing activities | 9,047 | 0 | 0 | 10,845 |
| Net increase in cash and cash equivalents | 5,338 | -3,020 | -2,270 | 5,160 |
| Beginning of period | 7,024 | -2,890 | 7,154 | - |
| End of period | 12,362 | -3,020 | 10,044 | - |